Review and comment rules of national key monitoring drug prescriptions （medical orders）

YANG Liu; HAN Yong; SHEN Qing; ZHOU Yimeng; REN Wei; YAN Junfeng; TONG Rongsheng

doi:10.6039/j.issn.1001-0408.2023.21.01

您当前的位置：

首页 >

文章列表页 >

Review and comment rules of national key monitoring drug prescriptions （medical orders）

更新时间：2025-09-23

- Review and comment rules of national key monitoring drug prescriptions （medical orders）
- ZHONGGUO YAOFANG Vol. 34, Issue 21, Pages: 2561-2577(2023)
- 作者机构：
  
  1.四川省医学科学院·四川省人民医院药学部，成都　610072
  2.电子科技大学医学院个体化药物治疗四川省重点实验室，成都　610072
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.21.01
  CLC： R95
- Received：30 July 2023，
  
  Revised：2023-08-14，
  
  Accepted：15 August 2023，
  
  Published：15 November 2023
- 稿件说明：
移动端阅览
阳柳,韩勇,申青,等.国家重点监控药品处方（医嘱）审核点评规则 [J].中国药房,2023,34(21):2561-2577.

YANG Liu,HAN Yong,SHEN Qing,et al.Review and comment rules of national key monitoring drug prescriptions （medical orders）[J].ZHONGGUO YAOFANG,2023,34(21):2561-2577.
阳柳,韩勇,申青,等.国家重点监控药品处方（医嘱）审核点评规则 [J].中国药房,2023,34(21):2561-2577. DOI： 10.6039/j.issn.1001-0408.2023.21.01.

YANG Liu,HAN Yong,SHEN Qing,et al.Review and comment rules of national key monitoring drug prescriptions （medical orders）[J].ZHONGGUO YAOFANG,2023,34(21):2561-2577. DOI： 10.6039/j.issn.1001-0408.2023.21.01.

摘要

为规范各级医疗机构对国家重点监控药品处方（医嘱）的审核点评工作，由四川省医学科学院·四川省人民医院牵头，根据国家卫生健康委于2023年1月13日确定的《第二批国家重点监控合理用药药品目录》（以下简称《目录》），组织编写了《国家重点监控药品处方（医嘱）审核点评规则》（以下简称《规则》）。编写组依据国家药品监督管理部门发布的法律法规及药品说明书、临床指南、专家共识等文献资料，结合患者的实际情况（包括年龄、体重和肝肾功能等因素），对《目录》中30种药品的常见不合理用药问题进行分类，并制定审核点评细则，经过2轮德尔菲法线上问卷调查，并通过2次专家线上会议充分讨论后经指导委员会审核，形成最终《规则》。本《规则》旨在为医疗机构开展《目录》中药品的合理用药评价提供参考，进而实现国家重点监控药品的规范化管理，促进医疗机构合理用药，保障患者用药安全。

Abstract

In order to standardize the review and comment of national key monitoring drug prescriptions （medical orders） by medical institutions at all levels， the Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital took the lead in compiling the

Review and Comment Rules of National Key Monitoring Drugs prescriptions

（

Medical Orders

）

herein after referred to as the

Rules

in accordance with the

Second Batch of National Key Monitoring Rational Drug Use List

（hereinafter referred to as the

List

） issued by the National Health Commission confirmed in Jan. 13， 2023. According to the laws and drug instructions issued by the national drug regulatory department， clinical guidelines and expert consensus， combined with the actual situation of patients （including age， body weight， liver and kidney function）， the writing group classified the common and unreasonable drug use problems for 30 kinds of drugs included in the

List

and develop the review and comment details. After two rounds of Delphi method questionnaire research and experts’ online meetings， and reviewed by the steering committee， the final

Rules

was formed. The

Rules

aim to provide reference for the evaluation of the rational use of drugs included in the

List

by medical institutions， so as to realize the standardized management of key monitoring drugs， promote the rational drug use in medical instituti

ons， and ensure the safety of drug use for patients.

关键词

Keywords

references

周萍，闫晓萌 . 以绩效考核为导向的合理用药管控机制探索与实践 [J ] . 中国药房， 2023 ， 34 （ 13 ）： 1646 - 1650 .

ZHOU P ， YAN X M . Exploration and practice of rational drug use control mechanism based on performance appraisal [J ] . China Pharm ， 2023 ， 34 （ 13 ）： 1646 - 1650 .

边原，陈岷，杜姗，等 . 第二批国家重点监控药品合理使用规范 [J ] . 中国药房， 2023 ， 34 （ 20 ）： 2433 - 2453 .

BIAN Y ， CHEN M ， DU S ， et al . Principles for the rational use of national key monitoring drugs（the second batch） [J ] . China Pharm ， 2023 ， 34 （ 20 ）： 2433 - 2453 .

Views

320

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Principles for the rational use of national key monitoring drugs （the second batch）

Construction of the management index system for the management of off-label drug use in the hospital based on Delphi method

Survey on the perception and current status of drug risk management in medical institutions

Related Author

YANG Liu

HAN Yong

SHEN Qing

ZHOU Yimeng

REN Wei

YAN Junfeng

TONG Rongsheng

BIAN Yuan

Related Institution

School of Medicine， University of Electronic Science and Technology of China

Personalized Drug Therapy Key Laboratory of Sichuan Provincial， Dept. of Pharmacy， Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital/Affiliated Hospital of UESTC

Dept. of Pharmacy/Sichuan Provincial Key Laboratory of Personalized Drug Therapy， the Affiliated Hospital of University of Electronic Science and Technology of China

Personalized Drug Therapy Key Laboratory of Sichuan Provincial，Dept. of Pharmacy，Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital/ Affiliated Hospital of UESTC

Dept. of Pharmacy， Peking Union Medical College Hospital， Chinese Academy of Medical Sciences

⁰